Article | Taska | Subjectsb | Doses/Frequencyc | Timelined | Effectse |
---|---|---|---|---|---|
Harper et al., 2005 | DMS | Rats (SD), Adult, Male | 0.3, 1, 2, or 3 mg/kg (i.p.)* | Training: Predrug / Testing: On-Drug | ⌀ |
Harper, 2011 | DMS | Rats (SD), Adult, Male | 3 mg/kg (i.p.)* | Training: Predrug / Testing: On-Drug | ⌀ |
Frederick et al., 1995a | DMS | Monkeys (R), Adult, Male | 0.1, 0.3, or 1 mg/kg (i.m.)* | Training: Predrug / Testing: On-Drug | ⌀ |
Frederick et al., 1995b | DMS | Monkeys (R), Adult, Male | 0.1 → 0.3 → 1 → 3 → 5.6 → 10 → 20 (14 days each) mg/kg (i.m.) × 2/day, 14 wk AND 0.3, 1, 1.75 or 3 mg/kg (i.m.)* | Training: Predrug / Testing: On-Drug | ⌀ |
LeSage et al., 1993 | DMS | Pigeons (WC), Adult | 0.32, 1, 1.7, 3.2, or 4.2 mg/kg (i.m.)* AND 3.2 (20 days) → 4.2 (1 day) → 3.2 (5 days) → 5.6 (1 day) mg/kg (i.m.) × 1/day, 27 days | Training: Predrug / Testing: On-Drug | ⌀ |
Taffe et al., 2001 | DNMS | Monkeys (R), Adult, Male | 10 mg/kg (i.m.) × 2/day, 4 days | Training: Predrug / Testing: On-Drug, Postdrug | ⌀ |
Marston et al., 1999 | DNMS | Rats (LH), Adult, Male | 10 → 15 → 20 (1 day each) mg/kg (i.p.) × 2/day, 3 days | Training: Predrug / Testing: Postdrug | ↓ |
Hawkey et al., 2014 | OST | Rats (SD), Adult, Male | 0.3, 1, 1.8, or 3 mg/kg (i.p.)* OR 10 mg/kg (i.p.) × 2/day, 4 days | Training: Predrug / Testing: On-Drug (Single), Postdrug (Repeated) | ⌀ |
Costa et al., 2014 | SA | Mice (B6), Adol.→Adult, Male | 10 mg/kg (i.p.) × 2/day, 2 days/wk (spaced), 9 wk | Testing: Off-Drug1, Postdrug | ⌀ |
Edut et al., 2011 | SA | Mice (ICR), Adult, Male | 10 mg/kg (i.p.) × 1 | Testing: Postdrug | ⌀ |
Cassel et al., 2005 | SA | Rats (LE), Adult, Male | 10 mg/kg (i.p.) × 1/day, 4 days | Testing: Postdrug | ⌀ |
Kolyaduke and Hughes, 2013 | SA | Rats (PVG/c), Adol.→Adult, Male/Female | 10 mg/kg (i.p.) × 1/day, 10 days | Testing: Postdrug | ⌀ |
Ricaurte et al., 1993 | DA | Rats (LE), Adult, Male | 20 mg/kg (s.c.) × 2/day, 4 days/wk, 2 wk (spaced) | Training/Testing: Postdrug | ⌀ |
Young et al., 2005 | DA | Rats (W), Adult, Male | 1.25, 2.25, or 5 mg/kg (i.p.)* | Training: Predrug / Testing: On-Drug | ⌀ (1.25 and 2.25 mg/kg) ↓ (5 mg/kg) |
Viñals et al., 2012 | DA | Mice (B6), Adult, Male | 3 or 30 mg/kg (i.p.) × 2/day, 4 days | Training: Predrug / Testing: Postdrug | ⌀ |
Hernandez-Rabaza et al., 2010 | RAM | Rats (LE), Adol., Male | 10 mg/kg (i.p.) × 2 | Training: Postdrug | ⌀ |
Ros-Simó et al., 2013 | RAM | Mice (CD1), Adol., Male | 20 mg/kg (i.p.) × 2 | Training: Predrug, Off-Drug2, Postdrug | ⌀ |
Kay et al., 2010 | RAM | Rats (SD), Adult, Male | 0.75, 3, or 4 mg/kg (i.p.)* | Training: Predrug, On-Drug | ⌀ (0.75 and 3 mg/kg) ↓ (4 mg/kg) |
Kay et al., 2011 | RAM | Rats (SD), Adult, Male | 10 mg/kg (i.p.) × 4 AND 4 mg/kg (i.p.)* | Training: Postdrug (10 mg/kg) and On-Drug (4 mg/kg) | ⌀ |
Harper et al., 2013 | RAM | Rats (SD), Adult, Male | 10 mg/kg (i.p.) × 4 AND/OR 4 mg/kg (i.p.) × 1/wk, 6 wk | Training: Postdrug (10 mg/kg) and On-Drug (4 mg/kg) | ⌀ |
Braida et al., 2002 | RAM | Rats (W), Adult, Male | 1, 2, or 3 mg/kg (i.p.) × 1/day, 3 days | Training: Predrug, On-Drug | ⌀ (1 and 2 mg/kg) ↓ (3 mg/kg) |
Robinson et al., 1993 | MWM | Rats (SD), Adult, Male | 10 mg/kg (i.p.) × 2/day, 4 days | Training: Postdrug | ⌀ |
Galizio et al., 2014 | MWM | Rats (SD), Adult, Male | 0.3, 1, 1.7, 3, or 5.6 mg/kg (i.p.)* | Training: Predrug / Testing: On-Drug | ⌀ |
↵a Studies used the delayed matching-to-sample (DMS), delayed nonmatching-to-sample (DNMS), odor span task (OST), spontaneous alternation (SA), delayed alternation (DA), radial arm maze (RAM), and Morris water maze (MWM) tasks.
↵b Species (strain), age, and sex of subjects. Strains include rhesus (R) monkeys; White Carneau (WC) pigeons; Lister Hooded (LH), Long Evans (LE), PVG/c hooded, Sprague-Dawley (SD), and Wistar (W) rats; and C57BL/6 (B6), CD1, and ICR mice.
↵c Dose, route, and frequency of MDMA administration. Treatment days/weeks are consecutive unless noted as “spaced.”
↵d When training and testing occurred in relation to drug treatment. Pre- and post-drug training/testing were always conducted off-drug.
↵e Effects of drug treatment on nonspatial working memory [DMS/DNMS, OST, DA (only Viñals et al., 2012)] and spatial working memory [SA/DA (except Viñals et al., 2012), RAM, MWM]: ⌀ No Effect, ↓ Impairment, ↑ Enhancement.
1 Off-drug training/testing took place on day(s) without drug administration.
↵2 Off-drug training/testing took place immediately before drug administration on (last) day of treatment.
↵* Within-subjects design (all animals were tested multiple times at each dose including saline).